Willingness to pay and quality of life in patients with rosacea

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 6, 2013, Pages 734-738

  Beikert, F C ^a   Langenbruch, A K ^a   Radtke, M A ^a   Augustin, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATTITUDE TO HEALTH; CLINICAL FEATURE; DISEASE DURATION; FEMALE; GERMANY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; PRIORITY JOURNAL; QUALITY OF LIFE; ROSACEA; VITILIGO; WILLINGNESS TO PAY;

ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; FINANCING, PERSONAL; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; ROSACEA; VOLITION;

EID: 84877631119     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04549.x     Document Type: Article

References (31)

1. Lomholt G,. Prevalence of skin diseases in a population; a census study from the Faroe Islands. Dan Med Bull 1964; 11: 1-7.
2. Berg M, Lidén S,. An epidemiological study of rosacea. Acta Derm Venereol 1989; 69: 419-423.
3. Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I,. Prevalence of skin lesions and need for treatment in a cohort of 90,880 workers. Br J Dermatol 2011; 165: 865-873.
4. Powell FC,. Clinical practice.Rosacea. N Engl J Med 2005; 352: 793-803.
5. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002; 46: 584-587.
6. Wolf JE, del Rosso JQ,. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis 2007; 79: 73-80.
7. Shuster S, Fisher GH, Harris E, Binnell D,. The effect of skin disease on self image [proceedings]. Br J Dermatol. 1978; 99 (Suppl. 16): 18-19.
8. Roosta N, Black DS, Peng D, Riley LW,. Skin disease and stigma in emerging adulthood: impact on healthy development. J Cutan Med Surg 2010; 14: 285-290.
9. Su D, Drummond PD,. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother 2011. Jun 23. doi: 10.1002/cpp.763. [Epub ahead of print].
10. Gupta MA, Gupta AK, Chen SJ, Johnson AM,. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol 2005; 153: 1176-1181.
11. The Euro Qol group. Euro Qol-a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199-208.
12. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
13. O'Brien B, Gafni A,. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care Med Decis Making 1996; 16: 288-299.
14. Motley RJ, Finlay AY,. How much disability is caused by acne? Clin Exp Dermatol 1989; 14: 194-188.
15. Lundberg L, Johannesson M, Silverdahl M, et al. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999; 141: 1067-1175.
16. Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M,. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol 2009; 161: 134-139.
17. Schmitt J, Meurer M, Klon M, Frick KD,. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol 2008; 158: 351-359.
18. Cham PM, Chen SC, Grill JP, Jonk YC, Warshaw EM,. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis. Br J Dermatol 2007; 156: 922-928.
19. Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U,. Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis. Hautarzt 1999; 50: 715-722.
20. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY,. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
21. Menezes N, Moreira A, Mota G, Baptista A,. Quality of life and rosacea: pulsed dye laser impact. J Cosmet Laser Ther 2009; 11: 139-141.
22. Weissenbacher S, Merkl J, Hildebrandt B, et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol 2007; 156: 728-732.
23. Aksoy B, Altaykan-Hapa A, Egemen D, Karagöz F, Atakan N,. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol 2010; 163: 719-725.
24. Harlow D, Poyner T, Finlay AY, Dykes PJ,. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000; 143: 979-982.
25. Lewis V, Finlay AY,. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004; 9: 169-180.
26. Weiss SC, Nguyen J, Chon S, Kimball AB,. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis. J Drugs Dermatol 2005; 4: 339-345.
27. Shikiar R, Willian MK, Okun MM, et al. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006; 4: 71.
28. Revicki D, Willian MK, Saurat JH, et al. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol 2008; 158: 549-557.
29. Schiffner R, Schiffner-Rohe J, Gerstenhauer M, et al. Willingnessto-pay and time-trade-off: sensitive to changes of quality of life in psoriasis patients? Br J Dermatol 2003; 148: 1153-1160.
30. Finlay AY, Coles EC,. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-244.
31. Lachaine J, Laurier C, Contandriopoulos AP,. Defining monetary values for quality of life improvements: an exploratory study. Pharmacoeconomics 2003; 21: 865-874.